Picture of Sapporo Clinical Laboratory logo

9776 — Sapporo Clinical Laboratory News Story

0.000.00%
jp flag iconLast trade - 00:00
Consumer DefensivesBalancedMicro CapSuper Stock

Table: Sapporo Clinical Lab -2016/17 parent results

May 12 (Reuters)-  
          Sapporo Clinical Laboratory Co Ltd  
          PARENT-ONLY FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified) 
                 Year ended      Year ended       Year to     NEXT      
              Mar 31, 2017    Mar 31, 2016   Mar 31, 2018     YEAR      
                 LATEST         YEAR-AGO        COMPANY      COMPANY    
                 RESULTS         RESULTS       FORECAST    H1 FORECAST  
  Sales           15.87           16.27          16.29         8.09     
               (-2.5 pct)      (+3.4 pct)     (+2.7 pct)    (+2.9 pct)  
  Operating      734 mln         933 mln                                
               (-21.3 pct)     (+11.9 pct)                              
  Recurring      764 mln         961 mln        726 mln      337 mln    
               (-20.4 pct)     (+11.0 pct)    (-5.0 pct)    (-4.4 pct)  
  Net            488 mln         569 mln        490 mln      227 mln    
               (-14.3 pct)     (+1.9 pct)     (+0.5 pct)    (-0.8 pct)  
  EPS          140.39 yen      163.80 yen     141.10 yen    65.48 yen   
  Ann Div       10.00 yen       11.00 yen      10.00 yen                
  -Q2 Div          NIL             NIL            NIL                   
  -Q4 Div       10.00 yen       11.00 yen      10.00 yen                
   
  NOTE - Sapporo Clinical Laboratory Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=9776.T 
  ((Tokyo Headline News Desk +813 6441 1812))

Recent news on Sapporo Clinical Laboratory

See all news